Viewing Study NCT00326157


Ignite Creation Date: 2025-12-24 @ 6:45 PM
Ignite Modification Date: 2026-03-27 @ 8:43 PM
Study NCT ID: NCT00326157
Status: COMPLETED
Last Update Posted: 2010-02-12
First Post: 2006-05-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation
Sponsor: Gilead Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fungus Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None antifungal primary prophylaxis treatment View
None allogeneic stem-cell transplantation View
None antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic … View